TY  - GEN
AU  - Cavallari,L H
AU  - Beitelshees,A L
AU  - Blake,K V
AU  - Dressler,L G
AU  - Duarte,J D
AU  - Elsey,A
AU  - Eichmeyer,J N
AU  - Empey,P E
AU  - Franciosi,J P
AU  - Hicks,J K
AU  - Holmes,A M
AU  - Jeng,Ljb
AU  - Lee,C R
AU  - Lima,J J
AU  - Limdi,N A
AU  - Modlin,J
AU  - Obeng,A O
AU  - Petry,N
AU  - Pratt,V M
AU  - Skaar,T C
AU  - Tuteja,S
AU  - Voora,D
AU  - Wagner,M
AU  - Weitzel,K W
AU  - Wilke,R A
AU  - Peterson,J F
AU  - Johnson,J A
TI  - The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting
SN  - 1752-8062
PY  - 2019///0107
KW  - Animals
KW  - Biomedical Research
KW  - organization & administration
KW  - Consensus
KW  - Cooperative Behavior
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - diagnosis
KW  - Evidence-Based Medicine
KW  - Genotype
KW  - Humans
KW  - Interdisciplinary Communication
KW  - National Institutes of Health (U.S.)
KW  - Pharmacogenetics
KW  - Pharmacogenomic Variants
KW  - genetics
KW  - Phenotype
KW  - Practice Guidelines as Topic
KW  - Risk Assessment
KW  - United States
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1111/cts.12456
ER  -